Drug Type ASO |
Synonyms SYNGAP1 ASO (Acadia/Stoke Therapeutics) |
Target |
Mechanism SYNGAP1 inhibitors(Ras GTPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Preclinical | US | 12 Jul 2024 | |
Epilepsy | Preclinical | US | 12 Jul 2024 | |
Intellectual Disability | Preclinical | US | 12 Jul 2024 | |
Intellectual Disability | Preclinical | US | 12 Jul 2024 |